AMY NELSON: Open Payments
NPI 1790109338 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 28 payments from 13 companies in 2025. Trend: 2023 $82 · 2024 $254 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $129 |
| Phathom Pharmaceuticals, Inc. | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| PFIZER INC. | 3 | $49 |
| ABBVIE INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $18 |
Products named: Ozempic, VOQUEZNA, NURTEC ODT, UBRELVY, LEQVIO, REXULTI, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
